Experimental Encephalomyocarditis Virus Infection in Small Laboratory Rodents

Journal of Comparative Pathology

Volumn 144, Issue 1, 2011, Pages 25-40

  Doi, K ^a,b  

^a NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Encephalomyocarditis virus; Pathogenesis; Pathology; Small laboratory rodents

Indexed keywords

CD4 ANTIBODY; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BAGG ALBINO MOUSE; BLOOD BRAIN BARRIER; BOVINE VIRAL DIARRHEA; BRAIN DAMAGE; BRAIN NECROSIS; CD4+ T LYMPHOCYTE; COXSACKIE VIRUS B; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE CARRIER; ENCEPHALOMYELITIS; ENCEPHALOMYOCARDITIS VIRUS; EXOCRINE GLAND; EXPERIMENTAL ANIMAL; FOOT AND MOUTH DISEASE VIRUS; GERBIL; GUINEA PIG; HAMSTER; HINDLIMB; HIPPOCAMPUS; IMMUNE RESPONSE; INFECTION SENSITIVITY; INOCULATION; LATENT RAT PARVOVIRUS; LYMPHOCYTE DEPLETION; MALE STERILITY; MENGO VIRUS; MUMPS; MUMPS VIRUS; MYOCARDITIS; NATURAL KILLER CELL; NONHUMAN; ORCHITIS; PARALYSIS; PATHOGENESIS; PRIORITY JOURNAL; REOVIRUS; RETROVIRUS; REVIEW; RODENT; RUBELLA VIRUS; SIALODACRYOADENITIS; STRATUM PYRAMIDALE; VIRUS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; BRAIN; CARDIOVIRUS INFECTIONS; CRICETINAE; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; DISEASE RESERVOIRS; ENCEPHALOMYELITIS; ENCEPHALOMYOCARDITIS VIRUS; GERBILLINAE; GUINEA PIGS; HUMANS; MALE; MESOCRICETUS; MICE; MYOCARDITIS; ORCHITIS; RATS; SIALADENITIS;

CARDIOVIRUS; ENCEPHALOMYOCARDITIS VIRUS; PICORNAVIRIDAE; RATTUS; RODENTIA;

EID: 78650304333     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2010.05.001     Document Type: Review

References (145)

1. Abzug M.J. Identification of trophoblastic giant cells as the initial principal target of early gestational murine enterovirus infection. Placenta 1993, 14:137-148.
2. Abzug M.J. Characterization of the placental barrier to murine enterovirus infection. Placenta 1994, 16:207-219.
3. Acland H.M. Encephalomyocarditis virus. Virus Infections of Porcines 1989, 259-264. Elsevier Science, Amsterdam. M.B. Penseart (Ed.).
4. Acland H.M., Littlejohns I.R. Encephalomyocarditis virus infection. Disease of Swine 1986, 399-402. Iowa State University Press, Ames. 6th Edit. A.D. Leman, B. Straw, R.D. Glock, W.L. Mengeling, R.H.C. Penny (Eds.).
5. Bae Y.S., Eun H.M., Yoon J.M. Molecular identification of viral gene. Diabetes 1989, 38:316-320.
6. Bae Y.S., Eun H.M., Yoon J.W. Genetic difference between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus. Virology 1989, 170:282-287.
7. Bae Y.S., Yoon J.W. A single gene of the host and a single amino acid of a virus control the development of type 1 diabetes in mice. Diabetes 1991, 40:435-443.
8. Baek H.S., Yoon J.W. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. Journal of Virology 1990, 64:5708-5715.
9. Baek H.S., Yoon J.M. Direct involvement of macrophages in destruction of β-cells leading to development of diabetes in virus-infected mice. Diabetes 1991, 40:1586-1597.
10. Barger M.T., Craighead J.E. Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice. Journal of Virology 1991, 65:676-681.
11. Billinis C., Paschaleri-Papadopoulou E., Anastasiadis G., Psychas V., Vlemmas J., et al. A comparative study of the pathogenetic properties and transmissibility of a Greek and a Belgian encephalomyocarditis virus (MCV) for piglets. Veterinary Microbiology 1999, 70:179-192.
12. Birgley N.J., Blay R.A., Smith R.A. Impaired cytokine response in male ICR Swiss mice after infection with D variant of encephalomyocarditis virus. Diabetes 1987, 36:1408-1413.
13. Bogen C., Gilden D.H., Wroblewska Z., Wolinsky S. Experimental infection of human leukocytes with parainfluenza 1 (6/94) virus. Infection and Immunity 1977, 18:501-508.
14. Brewer L.A., Lwamba H.C., Murtaugh M.P., Palmenberg A.C., Brown C., et al. Porcine encephalomyocarditis virus persists in pig myocardium and infects human myocardial cells. Journal of Virology 2001, 75:11621-11629.
15. Carmichael L.E., Kenny R.M. Canine abortion caused by Brucella canis. Journal of the American Veterinary Medical Association 1968, 152:605-616.
16. Choi K.S., Jun H.S., Kim H.N., Park H.J., Eom Y.W., et al. Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. Journal of Virology 2001, 75:1949-1957.
17. Craighead J.E. Necrosis of the pancreas, parotid and lachrymal glands associated with encephalomyocarditis virus infection. Nature 1965, 207:1268-1269.
18. Craighead J.E. Pathogenicity of M and E variants of encephalomyocarditis (EMC) virus. I. Myocardiotropic and neurotropic properties. American Journal of Pathology 1966, 48:333-345.
19. Craighead J.E. Pathogenicity of the M and E variants of the encephalomyocarditis (EMC) virus. II. Lesions of the pancreas, parotid and lacrimal glands. American Journal of Pathology 1966, 48:375-386.
20. Craighead J.E., Huber S.A., Sriram S. Biology of disease. Animal models of picornavirus-induced autoimmune disease: their possible relevance to human disease. Laboratory Investigation 1990, 63:432-446.
21. Craighead J.E., McLean M.F. Diabetes mellitus induction in mice by encephalomyocarditis virus. Science 1968, 162:913-914.
22. Cronin M.E., Love L.A., Miller F.W., McClintock P.R., Plotz P.H. The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral persistence demonstrated by in situ hybridization. Journal of Experimental Medicine 1988, 168:1639-1648.
23. Dejucq N., Chousterman S., Jegou B. The testicular antiviral defence system: localization, expression and regulation of 2'5'oligoadenylate synthetase, double-stranded RNA-activated protein kinase and Mx proteins in the rat seminiferous tubule. Journal of Cellular Biology 1997, 139:865-873.
24. Dejucq N., Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiology and Molecular Biology Reviews 2001, 65:208-231.
25. Doi C., Takeda M., Hirasawa K., Doi K. Transmissibility of the D variant of encephalomyocarditis virus (EMC-D) in mice. Laboratory Animals 1993, 27:222-225.
26. Doi K., Onodera T., Tsuda T., Matsuzaki H., Mitsuoka T. Histopathology of BALB/c mice infected with the D variant of encephalomyocarditis virus. British Journal of Experimental Pathology 1988, 69:395-401.
27. Doi K., Yasoshima A., Kojima A., Okawa H., Kurabe S., et al. Pathological observations on natural cases of sialodacryoadenitis of rats. Experimental Animals 1980, 29:419-426.
28. Esfandiarei M., McManus B.M. Molecular biology and pathogenesis of viral myocarditis. Annual Review of Pathology: Mechanisms of Disease 2008, 3:127-155.
29. Eun H.M., Bae Y.S., Yoon J.W. Amino acid differences in capsid protein, VP-1, between diabetogenic and non-diabetogenic variants of encephalomyocarditis virus. Virology 1988, 163:902-905.
30. Exley M.A., Bigley N.J., Cheng O., Shaulov A., Tahir S.M.A., et al. Innate immune response to encephalomyocarditis virus infection mediated by CD1. Immunology 2003, 110:519-526.
31. Fazakerley J.K., Southern P., Bloom F., Buchmeier M.J. High resolution in situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in tissues of persistently infected mice. Journal of General Virology 1991, 72:1611-1625.
32. Findlay G.M., Howard E.M. The susceptibility of rats to encephalomyocarditis viruses. British Journal of Experimental Pathology 1951, 32:569-572.
33. Grobler D.G., Raath J.P., Braak L.E.O., Keet D.F., Gerdes G.H., et al. An outbreak of encephalomyocarditis-virus infection in free-ranging African elephants in the Kruger National Park. Ondesterpoort Journal of Veterinary Research 1995, 62:97-108.
34. Helwig F.C., Schmidt E.C.H. A filter-passing agent producing interstitial myocarditis in anthropoid apes and small animals. Science 1945, 102:31-33.
35. Hill B.D., Ketterer P.J., Rodwell B.J., Eaves F.W., Webster W.R. Encephalomyocarditis virus infection and pig disease in Queensland. Australian Veterinary Journal 1985, 62:433-434.
36. Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin-6. Immunology Today 1990, 11:443-449.
37. Hirasawa K., Han J.S., Takeda M., Itagaki S., Doi K. Encephalomyocarditis (EMC) virus-induced myocarditis by different virus variants and mouse strains. Journal of Veterinary Medical Science 1992, 54:1125-1129.
38. Hirasawa K., Jun H.S., Han H.S., Zhang M.L., Hollenberg M.D., et al. Prevention of encephalomyocarditis virus-induced diabetes in mice by inhibition of the tyrosine kinase signaling pathway and subsequent suppression of nitric oxide production in macrophages. Journal of Virology 1999, 73:8541-8548.
39. Hirasawa K., Jun H.S., Maeda K., Kawaguchi Y., Itagaki S., et al. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. Journal of Virology 1997, 71:4024-4031.
40. Hirasawa K., Kim A., Han H.S., Han J., Jun H.S., et al. Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus. Journal of Virology 2003, 77:5649-5656.
41. Hirasawa K., Ogiso Y., Takeda M., Lee M.J., Itagaki S., et al. Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus. Laboratory Animal Science 1995, 45:652-656.
42. Hirasawa K., Takeda M., Matsuzaki H., Doi K. Encephalomyocarditis (EMC) virus-induced orchitis in Syrian hamsters. International Journal of Experimental Pathology 1991, 72:617-622.
43. Hirasawa K., Takeda M., Itagaki S., Doi K. Involvement of macrophages in the development of encephalomyocarditis virus (EMCV)-induced diabetes in mice. Experimental Animals 1996, 45:77-80.
44. Hirasawa K., Tsutsui S., Takeda M., Mizutani M., Itagaki S., et al. Depletion of Mac1-positive macrophages protects DBA/2 mice from encephalomyocarditis virus-induced myocarditis and diabetes. Journal of General Virology 1996, 77:737-741.
45. Holyoak G.R., Giles R.C., McCollum W.H., Little T.V., Timoney P.J. Pathological changes associated with equine arteritis virus RNA in the infection of reproductive tract in prepubertal and peripubertal. Journal of Comparative Pathology 1993, 109:281-293.
46. Horn G., Bugawa T., Long C., Erlich H. Allelic sequence of the HLA-DQ loci: relationship to serology and to insulin-dependent diabetes susceptibility. Proceedings of the National Academy of Science of the United States of America 1988, 85:6012-6016.
47. Hubbard G.B., Soike K.F., Butler T.M., Carey K.D., Davis H., et al. An encephalomyocarditis virus epizootic in a baboon colony. Laboratory Animal Science 1992, 42:233-239.
48. Huber S.A. Heat-shock protein induction in adriamycin and picornavirus-infected cardiocytes. Laboratory Investigation 1992, 67:218-224.
49. Huber S.A. VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells. Journal of Virology 1994, 68:3453-3458.
50. Ikegami H., Takeda M., Doi K. An age-related change in susceptibility of rat brain to encephalomyocarditis virus infection. International Journal of Experimental Pathology 1997, 78:101-107.
51. Juhler M., Blasberg R.G., Fenstermacher J.D., Patlak C.S., Paulson O.B. A spatial analysis of blood brain barrier damage in experimental allergic encephalomyelitis. Journal of Cerebral Blood Flow and Metabolism 1985, 5:545-553.
52. Jun H.S., Yoon J.W. The role of viruses in type 1 diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 2001, 44:271-285.
53. Kanda T., Koike H., Arai M., Wilson J.E., Carthy C.M., et al. Increased severity of viral myocarditis in mice lacking lymphocyte maturation. International Journal of Cardiology 1999, 68:13-22.
54. Kanda T., McManus J.E.W., Nagai R., Imai S., Suzuki T., et al. Modification of viral myocarditis in mice by interleukin-6. Circulation Research 1996, 78:848-856.
55. Kang Y., Yoon J.W. A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induced diabetes in mice. Journal of General Virology 1993, 74:1207-1213.
56. Kilham L., Mason P., Davies J.N.P. Pathogenesis of fatal encephalomyocarditis (EMC) virus infections in Albino rats. Proceedings of the Society for Experimental Biology and Medicine 1955, 90:383-387.
57. Kim H.S., Christianson W.T., Joo H.S. Pathogenic properties of encephalomyocarditis virus isolated in swine fetuses. Archives of Virology 1989, 109:51-57.
58. King A.M.Q., Brown F., Christian P., Hovi T., Hyypia T., et al. Picornaviridae. Virus Taxonomy, Seventh Report of the International Committee for the Taxonomy of Viruses 2000, 657-673. Academic Press, New York. M.H.V. Van Regenmortel, C.M. Fauquert, D.H.L. Bishop, C.H. Calisher, E.B. Carsten (Eds.).
59. Kishimoto C., Abelmann W.H. In vivo significance of T cells in the development of Coxsackie virus B3 myocarditis in mice: immature but antigen-specific T cells aggravate cardiac injury. Circulation Research 1990, 67:589-598.
60. Kishimoto C., Hirano Y., Takada H. T cell-mediated immune response enhances the severity of myocarditis in secondary cardiotropic virus infection in mice. Basic Research in Cardiology 2001, 96:439-445.
61. Kishimoto C., Kawamata H., Sakai S., Shinohara H., Ochiai H. Enhanced production of macrophage inflammatory protein 2 (MIP-2) by in vitro and in vivo infections with encephalomyocarditis virus and modulation of myocarditis with an antibody against MIP-2. Journal of Virology 2001, 75:1294-1300.
62. Kishimoto C., Takada H., Kawamata H., Umatake M., Ochiai H. Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines. Journal of Pharmacology and Experimental Therapeutics 2001, 299:645-651.
63. Kishimoto C., Kuribayashi K., Masuda T., Tomioka N., Kawai C. Immunological behavior of lymphocytes in experimental viral myocarditis: significance of T-lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c nu/nu mice. Circulation 1985, 71:1247-1254.
64. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., Dipietro L.A., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
65. Koenen F., Vanderhallen H., Castryck F., Miry C. Epidemiologic, pathogenic and molecular analysis of recent encephalomyocarditis outbreaks in Belgium. Journal of Veterinary Medicine B 1999, 46:217-231.
66. Lindsley M.D., Rodriguez M. Characterization of the inflammatory responses in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. Journal of Immunology 1989, 142:2677-2682.
67. Lipton H.L. Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infection and Immunity 1975, 11:1147-1155.
68. Manson A.L. Mumps orchitis. Urology 1990, 36:355-358.
69. Matsumori A., Ninokawa Y., Yamaki A., Yamamoto K., Hwang M.-W., et al. Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-κB inhibitor. European Journal of Heart Failure 2004, 6:137-144.
70. Matsumori A., Okada I., Yamada T., Maruyama S., Kawai C. Pathogenesis of myocardial injury in myocarditis and cardiomyopathy. Japanese Circulation Journal 1991, 55:1132-1137.
71. Matsumori A., Tomioka N., Kawai C. Viral myocarditis: immunopathogenesis and the effect of immunosuppressive treatment in a murine model. Japanese Circulation Journal 1989, 53:58-60.
72. Matsuzaki H., Doi K., Mitsuoka T., Tsuda T., Onodera T. Experimental encephalomyocarditis virus infection in Mongolian gerbils (Meriones unguiculatus). Veterinary Pathology 1989, 26:11-17.
73. Matsuzaki H., Doi K., Doi C., Onodera T., Mitsuoka T. Susceptibility of four species of small rodents to encephalomyocarditis (EMC) virus infection. Experimental Animals 1989, 38:357-361.
74. Matthews R.E.F. The classification and nomenclature of viruses. Intervirology 1979, 11:133-135.
75. + spleen cells contain gamma interferon (IFN-γ) gene transcripts in the early, sex-dependent production of IFN-γ after picornavirus infection. Journal of Virology 1990, 64:4407-4413.
76. Melaine N., Ruffaul A., Dejucq-Rainsford N., Jégou B. Experimental inoculation of the adult rat testis with Sendai virus: effect on testicular morphology and leukocyte population. Human Reproduction 2003, 8:1574-1579.
77. Miller S.D., Katz-Levy Y., Neville K.L., Vanderlugt C.L. Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Advances in Virus Research 2001, 56:199-217.
78. Mizutani M., El-Fotoh M., Mori M., Ono K., Doi K., et al. In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/c AJcl mice. Archives of Virology 1996, 141:73-83.
79. Mizutani M., Hirasawa K., Takeda M., Doi K., Yukawa M., et al. Variation in serum creatine phosphokinase activity as indicated in two-phase EMC-D virus-induced myocarditis. Experimental Animals 1996, 45:333-338.
80. Moran J.M., Moxley M.A., Buller R.M.L., Corbett J.A. Encephalomyocarditis virus induced PKR-independent mitogen-activated protein kinase activation in macrophages. Journal of Virology 2005, 79:10226-10236.
81. Murane T.G., Craighead J.E., Mondragon H., Shelokov A. Fetal disease of swine due to encephalomyocarditis virus. Science 1960, 131:498-499.
82. Nakayama Y., Su W., Katayama K., Nakayama H., Doi K. The susceptibility of pregnant mice to encephalomyocarditis (EMC) virus infection on different days of gestation. Experimental Animals 2004, 53:165-169.
83. Nakayama Y., Su W., Ohguchi A., Nakayama H., Doi K. Experimental encephalomyocarditis virus infection in pregnant mice. Experimental and Molecular Pathology 2004, 77:133-137.
84. Nasu-Nishimura Y., Taniuchi Y., Nishimura T., Sakudo A., Nakajima K., et al. Cellular prion protein prevents brain damage after encephalomyelitis virus infection in mice. Archives of Virology 2008, 153:1007-1012.
85. Neu N., Beisel K.M., Traystman M.D., Rose N.R., Craig S.W. Autoantibodies specific for the cardiac myosin isoforms found in mice susceptible to Coxsackie virus B3-induced myocarditis. Journal of Immunology 1987, 138:2488-2492.
86. Nishio R., Matsumori A., Shioi T., Ishida H., Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation 1999, 100:1102-1108.
87. Nuovo G.J., Becker J., Simsir A., Margiotta M., Khalife G., et al. HIV-1nucleic acids localize to the spermatogonia and their progeny. American Journal of Pathology 1994, 144:1142-1148.
88. Ohguchi A., Nakayama Y., Doi C., Nakayama H., Doi K. Encephalomyocarditis (EMC) virus-induced sialodacryoadenitis in mice. Experimental and Molecular Pathology 2005, 78:58-63.
89. Ohguchi A., Nakayama Y., Yasoshim A., Doi C., Mikami T., et al. Encephalomyocarditis virus-induced apoptosis and ultrastructural changes in the lacrimal and parotid glands of mice. Experimental and Molecular Pathology 2006, 80:201-207.
90. Paschaleri-Papadopoulou E., Axiotis I., Laspidis C. Encephalomyocarditis of swine in Greece. Veterinary Record 1990, 126:364-365.
91. Petruccelli M.A., Hirasawa K., Takeda M., Itagaki S., Doi K. Cardiac and pancreatic lesions in guinea pigs infected with encephalomyocarditis (EMC) virus. Histology and Histopathology 1991, 6:167-170.
92. Pirhonen J., Sareneva T., Kurimoto M., Julkunen I., Matikainen S. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. Journal of Immunology 1999, 162:7322-7329.
93. Poretsky L., Can S., Zumoff B. Testicular dysfunction in human immunodeficiency virus-infected men. Metabolism 1995, 44:946-953.
94. Powell M.B., Miychell D., Lederman J. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. International Immunology 1990, 2:539-546.
95. Psalla D., Psychas V., Spyrou V., Billinis C., Papaioannou N., et al. Pathogenesis of experimental encephalomyocarditis: a histological, immunohistochemical and virological study in rats. Journal of Comparative Pathology 2006, 134:30-39.
96. Psalla D., Psychas V., Spyrou V., Billinis C., Papaioannou N., et al. Pathogenesis of experimental encephalomyocarditis: a histological, immunohistochemical and virological study in mice. Journal of Comparative Pathology 2006, 135:142-145.
97. Psychas V., Papaioannou N., Billinis C., Paschaleri-Papadopoulou E., Leontides S., et al. Evaluation of ultrastructural changes associated with encephalomyocarditis virus in the myocardium of experimentally infected piglets. American Journal of Veterinary Research 2001, 62:1653-1657.
98. Pudney J., Anderson D. Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome. American Journal of Pathology 1991, 139:149-160.
99. Racaniello V.R. Picornaviridae: the viruses and their replication. Fields Virology 2001, 685-722. Lippincott Williams and Wilkins, Philadelphia. 4th Edit. M.K. Devid, M.H. Peter (Eds.).
100. Rodriguez M., Leibowitz J.L., Lampert P.W. Persistent infection of oligodendrocytes in Theiler's virus-infected encephalomyocarditis. Annual of Neurology 1983, 13:426-433.
101. Rodriguez M., Pierce M.L., Thiemann R.L. Immunoglobulins stimulate central nervous system remyelination. Laboratory Investigation 1991, 64:358-370.
102. Rodriguez M., Sriram S. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. Journal of Immunology 1988, 140:2950-2955.
103. Rodriguez M., Zoecklein L.J., Howe C.L., Pavelko K.D., Gamez J.D., et al. Gamma interferon is critical for neuronal clearance and protection in a suitable mouse strain following early intracranial Theiler's murine encephalitis virus infection. Journal of Virology 2003, 77:12252-12265.
104. Rogers C., Klatt E.C. Pathology of the testis in acquired immunodeficiency syndrome. Histopathology 1988, 12:659-665.
105. Ruddle N.H., Bergman C.M., McGrath K.M. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalitis. Journal of Experimental Medicine 1990, 172:1193-1199.
106. Sato Y., Matsumori A., Sasayama S. Autoantibodies against vimentin in murine model of myocarditis. Autoimmunity 1994, 18:145-148.
107. Schwarz E.M., Badorff C., Hiura T.S., Wessely R., Badorff A., et al. NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice. Journal of Virology 1998, 72:5654-5660.
108. Serikawa T., Kondo Y., Takada H., Yamada J. Head-to-head type auto-spermagglutination with IgA antibody to acrosome induced by Brucella canis infection. Japanese Journal of Veterinary Medical Science 1984, 46:41-48.
109. Shafi R., Certis D.R., Giron D.J. Pathogenesis of the B variant of encephalomyocarditis virus. Journal of Medical Virology 1993, 40:193-199.
110. She J.X. Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunology Today 1996, 17:323-329.
111. Shigesato M., Hirasawa K., Takeda M., Doi K. Encephalomyocarditis (EMC) virus-induced testicular lesions in BALB/c mice. Laboratory Animals 1994, 28:330-334.
112. Shigesato M., Takeda M., Hirasawa S., Itagaki S., Doi K. Early development of encephalomyocarditis (EMC) virus-induced orchitis in Syrian hamsters. Veterinary Pathology 1995, 32:184-186.
113. Shioi T., Matsumori A., Sasayama S. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. Circulation 1996, 94:2930-2937.
114. Simpson C.F., Lewis A.L., Gaskin L.M. Encephalomyocarditis virus infection of captive elephants. Journal of the American Veterinary Medical Association 1977, 171:902-905.
115. Springer T.A. Adhesion receptors of the immune system. Nature 1990, 346:425-434.
116. Spyrou V., Maurice H., Billinis C., Papanastasopoulou M., Psalla D., et al. Transmission and pathogenicity of encephalomyocarditis virus (EMCV) among rats. Veterinary Research 2004, 35:113-122.
117. Sriram S., Topham D.J., Huang S.K., Rodriguez M. Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies. Journal of Virology 1989, 63:4242-4248.
118. Su W., Ikegami H., Nakayama Y., Suzuki K., Katayama K., et al. Susceptibility of primary culture neurons from rats of different ages to encephalomyocarditis (EMC) virus infection. Experimental and Molecular Pathology 2003, 75:160-164.
119. Su W., Ueno-Yamanouchi A., Uetsuka K., Nakayama H., Doi K. Age-related changes in susceptibility of rat brain slice cultures including hippocampus to encephalomyocarditis virus. International Journal of Experimental Pathology 1999, 80:349-355.
120. Sugawara Y., Hirasawa K., Takeda M., Han J.S., Doi K. Acute infection of encephalomyocarditis (EMC) virus in Syrian hamsters. Journal of Veterinary Medical Science 1991, 53:463-468.
121. Takeda M., Hirasawa K., Doi K. Lesions in the central nervous system of DBA/2 mice infected with the D variant of encephalomyocarditis virus (EMC-D). Journal of Veterinary Medical Science 1991, 53:1013-1017.
122. Takeda M., Itagaki S., Doi K. Biphasic disease of central nervous system induced in DBA/2 mice by the D variant of encephalomyocarditis virus (EMC-D). International Journal of Experimental Pathology 1993, 74:493-499.
123. Takeda M., Miura R., Shiota K., Hirasawa K., Lee M.J., et al. Distribution of viral RNA in the spinal cord of DBA/2 mice developing biphasic paralysis following infection with the D variant of encephalomyocarditis virus (EMC-D). International Journal of Experimental Pathology 1995, 76:441-447.
124. + T cells in biphasic hind limb paralysis induced by the D variant of encephalomyocarditis virus (EMC-D) in DBA/2 mice. Experimental Animals 2004, 53:31-35.
125. Tanaka T., Kanda T., McManus B.M., Kanai H., Akiyama H., et al. Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-α Journal of Molecular and Cellular Cardiology 2001, 33:1627-1635.
126. Taub D.D., Anver M., Oppenheim J.J., Longo D.L., Murphy W.J. T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes. Journal of Clinical Investigation 1996, 9:1931-1941.
127. Teodoro G., Branton P.E. Regulation of apoptosis by viral gene products. Journal of Virology 1997, 71:1739-1746.
128. Topham D.J., Adesina A., Shenoy M., Craighead J.E., Sriram S. Indirect role of T cells in development of polioencephalitis and encephalomyelitis induced by encephalomyocarditis virus. Journal of Virology 1991, 65:3238-3245.
129. Ueno A., Takeda M., Hirasawa K., Itagaki S., Doi K. Relation between distribution of viral RNA and development of histopathological changes in encephalomyocarditis virus-induced orchitis in mice. International Journal of Experimental Pathology 1996, 77:25-30.
130. Ueno A., Takeda M., Hirasawa K., Itagaki S., Doi K. Detection of viral RNA by electron microscopic in-situ hybridization (ISH-EM) in the germinal epithelium of mice infected with encephalomyocarditis (EMC) virus. Experimental Animals 1997, 46:79-81.
131. Van der Werf N., Kroese F.G.M., Rozing J., Hillebrands J.L. Viral infection as potential triggers of type 1 diabetes. Diabetes/Metabolism Research and Reviews 2007, 23:169-183.
132. Wada H., Kanda T., Fujii H., Maekawa N., Fujiwara H., et al. Tumor necrosis factor-α plays a protective role in acute viral myocarditis in mice. Circulation 2001, 103:743-755.
133. Wang W.-Z., Matsumori A., Yamada T., Shioi T., Okada I., et al. Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production. Circulation 1997, 99:245-251.
134. White L.L., Smith R.A. D variant of encephalomyocarditis virus (EMC-D)-induced diabetes following natural killer cell depletion in diabetes-resistant male C57BL/6J mice. Viral Immunology 1990, 3:67-76.
135. Yamada T., Matsumori A., Sasayama S. Therapeutic effects of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1993, 89:846-851.
136. Yamada T., Matsumori A., Wang W.Z., Ohashi N., Shiota K., et al. Apoptosis in congestive heart failure induced by viral myocarditis in mice. Heart and Vessels 1999, 14:29-37.
137. Yamada M., Zurbriggen A., Fujinami R.S. The relationship between viral RNA, myelin-specific mRNA and demyelination in central nervous system disease during Theiler's virus infection. American Journal of Pathology 1990, 137:1467-1479.
138. Yamanouchi-Ueno A., Nakayama Y., Doi K. Characteristics of testicular lesions in mice infected with a low dose of encephalomyocarditis (MC) virus. Experimental and Molecular Pathology 2004, 77:72-76.
139. Yeung M.C., Chang D.L., Camantigue R.E., Lau A.S. Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. Proceedings of the National Academy of Science of the United States of America 1999, 96:11860-11865.
140. Yoon J.W. Pathogenesis of IDDM: environmental factors. Textbook of Diabetes 1997, 14.1-14.14. Blackwell Scientific Publications, London. J. Pickup, G. William (Eds.).
141. Yoon J.W., Kim A.M., Jun H.S. Role of viruses in insulin-dependent diabetes mellitus. Diabetes in the New Millennium. Endocrinology and Diabetes 1999, 105-117. Research Foundation of the University of Sydney, Sydney. J.R. William (Ed.).
142. Yoon J.W., Lesniak M.A., Fussganger R., Notkins A.L. Genetic differences in susceptibility of pancreatic β-cells to virus-induced diabetes mellitus. Nature 1976, 264:178-180.
143. Yoon J.W., McClintock P.R., Onodera T., Notkins A.L. Virus-induced diabetes mellitus. XVIII. Inhibition by a non-diabetogenic variant of encephalomyocarditis virus. Journal of Experimental Medicine 1980, 152:872-892.
144. Yoon J.W., Rodriguez M.M., Currier C., Notkins A.L. Long-term complications of virus-induced diabetes in mice. Nature 1982, 296:566-569.
145. Zimmerman J.J. Encephalomyocarditis. Handbook of Zoonoses, Section B, Viral 1994, 423-436. CRC Press, Boca Raton. 2nd Edit. G.W. Beran, J.H. Steel (Eds.).